StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Dexketoprofen

HCID 667550
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
22161-81-5
Standard-SMILES
C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
InChIKey
DKYWVDODHFEZIM-NSHDSACASA-N
Summenformel
C16H14O3
Durchschnittliche Molmasse
254,28 g/mol
Monoisotopische Masse
254,09429431

Überblick

Dexketoprofen is a monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor and a cyclooxygenase 1 inhibitor. It is a member of benzophenones and a monocarboxylic acid. It is functionally related to a (S)-hydratropic acid.

Namen und Bezeichner

Bevorzugter Name
Dexketoprofen
IUPAC
(2S)-2-(3-benzoylphenyl)propanoic acid
Englischer Name
(S)-(+)-Ketoprofen
Summenformel
C16H14O3
Molmasse
254.28

Namen und Synonyme

DEXKETOPROFEN22161-81-5(S)-Ketoprofen(+)-KetoprofenArveles(+)-3-Benzoylhydratropic acidHydratropic acid, m-benzoyl-, (+)-Ketoprofen, (s)-(+)-(S)-m-Benzoylhydratropic aciddexketoprofeneDexketoprofeno(S)-3-Benzoyl-alpha-methylbenzeneacetic acid
Weitere Namen anzeigen
(2S)-2-(3-Benzoylphenyl)propanoic acidKeralDexktoprofenDexketoprofeexketoprofenlevoketoprofenDexketoprofen API
6KD9E78X68CHEBI:76128DTXSID40905141Benzeneacetic acid, 3-benzoyl-alpha-methyl-, (S)-dexketoprofen sodiumdexketoprofenumRefChem:132392M01AE17

Datenbank-Bezeichner

CAS
22161-81-5
PubChem CID
667550
DTXSID
DTXSID40905141
ChEMBL
CHEMBL75435
ChEBI
CHEBI:76128

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
3,1
Polarare Oberfläche (TPSA)
54,4 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
4
Schwere Atome
19
Formalladung
0
Komplexität
331

Physikochemische Eigenschaften

Schmelzpunkt
75 · 75-78 °C(lit.)
Siedepunkt
431.3 · 431.3±28.0 °C(Predicted)
Dichte
1.198 · 1.198±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
2 O; · insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥20.55 mg/mL in EtOH
pka
4.23 · 4.23±0.10(Predicted)
Aggregatzustand
White solid.
Farbe
White to off-white
InChI
InChI=1/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/s3
InChIKey
DKYWVDODHFEZIM-LBPXTSNRNA-N
SMILES
C1(=CC=CC([C@H](C)C(=O)O)=C1)C(=O)C1=CC=CC=C1 |&1:5,r|
CAS Datenbank
22161 · 22161-81-5(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 2.4% (1 of 42) of reports.

Danger

H301 (97.6%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationStatus: Active Update: 06-11-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/17708
Hazard Classes and CategoriesAcute Tox. 3 (97.6%)

Toxikologische Informationen

Drug Induced Liver Injury · 4 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

DEXKETOPROFEN

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1/PG 3
RTECS-Nr.
CY1572790
risk_code
22-36/37/38-50/53-25
hazard_code
Xn,T

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 4 Einträge

M - Musculo-skeletal system

M - Musculo-skeletal system

QM - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingHighly protein bound.
PharmacodynamicsThis drug is an isomer of ketoprofen. Dexketoprofen a propionic acid derivative with analgesic, anti-inflammatory, and antipyretic properties.
Mechanism of ActionIt is a non-steroidal anti-inflammatory drug (NSAID) that reduces prostaglandin synthesis via inhibition of cyclooxygenase pathway (both COX-1 and COX-2) activity.
Biological Half-Life1.65 h
Metabolism/Metabolites · 1 Eintrag

Dexketoprofen is highly lipophilic, and is metabolized in the liver by glucuronidation. In one study, after oral administration of 25 mg of dexketoprofen to young healthy adults, Tmax was approximately 30 min for a Cmax of 3.7 ± 0.72 mg/l. Dexketoprofen trometamol is metabolized by the hepatic cytochrome P450 enzymes (CYP2C8 and CYP2C9). Dexketoprofen trometamol has a number of metabolites, with hydroxyl derivatives making up the greatest volume. In humans, hydroxylation plays a minor role. Dexketoprofen is primarily conjugated to an acyl-glucuronide

MeSH Pharmacological Classification · 1 Eintrag

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Absorption, Distribution and Excretion

Zugehörige Reaktionen

8
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 650619
HRID 650619als Edukt
Reaktionsgleichung von HRID 1459039
HRID 1459039als Produkt
Reaktionsgleichung von HRID 1459041
HRID 1459041als Produkt
Reaktionsgleichung von HRID 1459042
HRID 1459042als Produkt
Reaktionsgleichung von HRID 1459043
HRID 1459043als Produkt
Reaktionsgleichung von HRID 1459044
HRID 1459044als Produkt
Reaktionsgleichung von HRID 1459045
HRID 1459045als Produkt
Reaktionsgleichung von HRID 1459046
HRID 1459046als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
UNII
6KD9E78X68
EC Number
606-944-5
Nikkaji
J389.200J
safety_code
26-60-61-45
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1Eye Irrit. 2Skin Irrit. 2STOT SE 3
· 4 Einträge

After oral ingestion, the Dexketoprofen onset of action is within 30 minutes. The plasma half-life of Dexketoprofen is about 4-6 hours. The Cmax is about 30 minutes

Approximately 70 to 80% of the ingested dose is recovered in the urine during the first 12 hours post-ingestion, mainly as the acyl-conjugated form of the drug.

<0.25 L/kg

Mainly cleared via glucuronide conjugation and followed by renal excretion, mainly unchanged.

Cellular LocationsMembrane

Anwendungen

VerwendenAnti-inflammatory; analgesic

Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea.